Posts for PURPLE BIOTECH LTD. ($PPBT)

Discover Purple Biotech's latest financial report highlighting the advancement of NT219 into Phase 2 trials for Head and Neck Cancer, crucial for investors and market positioning.

Explore Purple Biotech Ltd.'s January 2025 6-K filing detailing their ATM Agreement, fundraising efforts, and use of proceeds. Key insights on market strategy and corporate finance.